HPAPI Project Services Limited to Host Workshop Following the Highly Potent Active Pharmaceutical Ingredients Conference
SMi reports: The Highly Potent Active Pharmaceutical Ingredients conference will host a post-conference workshop on “Practical Steps for Delivering HPAPI Projects.”
London, United Kingdom, February 24, 2020 --(PR.com)-- On the 11th – 12th May 2020, industry professionals will convene in London to discuss the challenges of the HPAPI industry at the Highly Potent Active Pharmaceutical Ingredients conference.
The conference will focus on the growing HPAPI landscape driven by the demand for highly potent drugs in oncology, diabetes and autoimmune disease treatment. It will address the biggest challenges in the industry, including determining toxicology limits, assessing hazards, implementing risk procures, translating risk assessment into facility engineering, preventing and dealing with cross-contamination and adhering to GMP regulatory guidelines.
Following the conference, a workshop will be held by Justin Mason-Home, Director, HPAPI Project Services Limited, on the 13th of May to focus on “Practical Steps for Delivering HPAPI Projects.”
Biopharmaceutical companies embody application of the scientific method to identify and deliver new patient therapies. The same systematic, scientific principles should be used to develop and deliver research, development and production facilities that are fit for purpose and which protect healthy workers. The workshop will explore key steps in rolling out a HPAPI project, helping define and deliver HPAPI projects that are technically sound, based on justifiable data which can underpin robust and defensible investment.
Highlights include:
· Strategic HPAPI Project Considerations
· Hazard Assessment - It All Starts with the Hazard Process is Primary
· Real Risk Assessment - Risk to Product and Risk to Workers
· Facility Design Features
· Containment for Higher Risk Activities and Control for Lower Risk Activities
· Verification of Control/Containment Performance
· Occupational health and safety management systems
To find out more or register for the workshop and/or conference, visit: http://www.highlypotentapi.com/prcom3
Highly Potent Active Pharmaceutical Ingredients
Main conference: 11th-12th May 2020
Post-conference workshop day: 13th May 2020
London, UK
Sponsored by: BSP Pharmaceuticals
Exhibitor: Dec Group
To sponsor or exhibit at the conference, please contact Alia Malick on +44 (0) 207 827 6748 or amalick@smi-online.co.uk.
For all delegate enquiries, contact Dylan Brohm on +44 (0) 20 7827 1024 or dbrohm@smi-online.co.uk.
About SMi Group:
Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world's most forward-thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at http://www.smi-online.co.uk
The conference will focus on the growing HPAPI landscape driven by the demand for highly potent drugs in oncology, diabetes and autoimmune disease treatment. It will address the biggest challenges in the industry, including determining toxicology limits, assessing hazards, implementing risk procures, translating risk assessment into facility engineering, preventing and dealing with cross-contamination and adhering to GMP regulatory guidelines.
Following the conference, a workshop will be held by Justin Mason-Home, Director, HPAPI Project Services Limited, on the 13th of May to focus on “Practical Steps for Delivering HPAPI Projects.”
Biopharmaceutical companies embody application of the scientific method to identify and deliver new patient therapies. The same systematic, scientific principles should be used to develop and deliver research, development and production facilities that are fit for purpose and which protect healthy workers. The workshop will explore key steps in rolling out a HPAPI project, helping define and deliver HPAPI projects that are technically sound, based on justifiable data which can underpin robust and defensible investment.
Highlights include:
· Strategic HPAPI Project Considerations
· Hazard Assessment - It All Starts with the Hazard Process is Primary
· Real Risk Assessment - Risk to Product and Risk to Workers
· Facility Design Features
· Containment for Higher Risk Activities and Control for Lower Risk Activities
· Verification of Control/Containment Performance
· Occupational health and safety management systems
To find out more or register for the workshop and/or conference, visit: http://www.highlypotentapi.com/prcom3
Highly Potent Active Pharmaceutical Ingredients
Main conference: 11th-12th May 2020
Post-conference workshop day: 13th May 2020
London, UK
Sponsored by: BSP Pharmaceuticals
Exhibitor: Dec Group
To sponsor or exhibit at the conference, please contact Alia Malick on +44 (0) 207 827 6748 or amalick@smi-online.co.uk.
For all delegate enquiries, contact Dylan Brohm on +44 (0) 20 7827 1024 or dbrohm@smi-online.co.uk.
About SMi Group:
Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world's most forward-thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at http://www.smi-online.co.uk
Contact
SMi Group
Neill Howard
+44 (0) 20 7827 6164
http://www.highlypotentapi.com/pr3
Neill Howard
+44 (0) 20 7827 6164
http://www.highlypotentapi.com/pr3
Contact
Categories